微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1% | -25.37% | 81.82% | 102/159 | 1.36% | 恩华药业 | 13.56% | 行业排名> |
| 2026-03-31 | 0.55% | -12.7% | -62.33% | 102/159 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 1.46% | -51.33% | -31.78% | 93/159 | -4.32% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 2.14% | -14.74% | 59.7% | 92/159 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 1.34% | -15.72% | 112.7% | 90/159 | 0.34% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 0.63% | -37.62% | -79% | 92/159 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 3% | 44.23% | 19.52% | 79/159 | -9.4% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 2.51% | -10.99% | 57.86% | 92/159 | 4.26% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 1.59% | 15.22% | 57.43% | 93/159 | 2.68% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 1.01% | -0.98% | -51.44% | 93/159 | 2.33% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 2.08% | 0.48% | -26.24% | 88/159 | -0.94% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 2.82% | 18.99% | 104.35% | 94/159 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 1.38% | 10.4% | 35.29% | 95/159 | 1.49% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 1.02% | 2% | -50.72% | 90/159 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 2.07% | 23.95% | -12.66% | 98/159 | 0.84% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 2.37% | 5.33% | 89.6% | 92/159 | 2.87% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 1.25% | -37.19% | 25% | 101/159 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 1% | 7.53% | -40.12% | 90/159 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 1.67% | 109.59% | -25.78% | 101/159 | 0.87% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 2.25% | 138.93% | 13.07% | 102/159 | 4.45% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 1.99% | 84.26% | 113.98% | 98/159 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 0.93% | 181.82% | 105.34% | 96/159 | 2.48% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | -17.42% | -646.08% | -201.38% | 127/159 | 3.82% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | -5.78% | -280.63% | -635.19% | 106/159 | 3.15% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 1.08% | -50.68% | 227.27% | 99/159 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 0.33% | -64.52% | -89.66% | 81/159 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 3.19% | -17.14% | -0.31% | 102/159 | 2.62% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 3.2% | 23.55% | 46.12% | 85/159 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 2.19% | 12.31% | 135.48% | 83/159 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 0.93% | -23.77% | -75.84% | 87/159 | 2.44% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 3.85% | -22.85% | 48.65% | 97/159 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 2.59% | -22.92% | 32.82% | 87/159 | 7.2% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 1.95% | -22% | 59.84% | 82/159 | 4.62% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 1.22% | 35.56% | -75.55% | 75/159 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 4.99% | -30.89% | 48.51% | 84/159 | 9.61% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 3.36% | -35.14% | 34.4% | 72/159 | 8.3% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 2.5% | -29.78% | 177.78% | 76/159 | 5.55% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 0.9% | -46.75% | -87.53% | 63/159 | 2.11% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 7.22% | -29.77% | 39.38% | 69/159 | 6.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 5.18% | -28.16% | 45.51% | 50/159 | 5.7% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 3.56% | -22.78% | 110.65% | 55/159 | 3.56% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 1.69% | -28.69% | -83.56% | 48/159 | 2.69% | 德展健康 | 29.5% | 行业排名> |